>

Johnson Johnson Interest Coverage Over Time

<div class='circular--portrait' style='background:#FF6600;color: white;font-size:3em;padding-top: 40px;;'>JNJ</div>
JNJ -- USA Stock  

Earning Report: April 14, 2020  

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets. Please see Johnson Johnson Performance and Johnson Johnson Correlation.
View Competitors Fundamentals Over Time Against Interest Coverage For
Refresh
Johnson Johnson Interest Coverage is decreasing as compared to previous years. The last year's value of Interest Coverage was reported at 30.17. The current Earnings Before Interest Taxes and Depreciation Amortization EBITDA is estimated to increase to about 28 B, while Interest Expense is estimated to decrease to under 836.8 M.

Specify up to 10 symbols:


Cross Equities Interest Coverage Analysis

Compare Johnson Johnson and related stocks such as Gilead Sciences, Bristol Myers Squibb, Allergan Plc, Novartis AG, GlaxoSmithKline PLC, Eli Lilly And, Merck, Pfizer, Astrazeneca PLC Interest Coverage Over Time
Select Fundamental

20102011201220132014201520162017201820192020
81.403327.297111.111114.741237.05132.257318.291512.63337.61374.30854.4203
84.057112129.736815.557812.763510.271727.724618.428627.96729.01379.2493
32.466732.466757.667657.667657.667657.667657.667633.524633.524630.1733.9789
5.697311.846710.54469.95655.284616.11773.48655.6788136147158
49.841351.419475.288514710938.601145.104639.083233.072216.611217.048
3.7513.945519.114111.091212.167418.088814.73717.704619.34518.744816.1288
7.556911.434211.541616.228513.781812.997312.424614.608611.77527.66849.0886
25.771328.565720.26879.51795.410111.30228.42276.41715.44534.59754.7197

Johnson Johnson and related stocks such as Gilead Sciences, Bristol Myers Squibb, Allergan Plc, Novartis AG, GlaxoSmithKline PLC, Eli Lilly And, Merck, Pfizer, Astrazeneca PLC Interest Coverage description

My Equities

My Current Equities and Potential Positions

JNJ - USA Stock
Johnson Johnson
<div class='circular--portrait-small' style='background:#FF6600;color: white;font-size:1.1em;padding-top: 12px;;'>JNJ</div>
Johnson Johnson Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
RegionNorth America
ExchangeBATS Exchange
$131.13
Please see Johnson Johnson Performance and Johnson Johnson Correlation. Please also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page